2009
DOI: 10.1016/j.vascn.2008.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Drug induced shortening of the QT/QTc interval: An emerging safety issue warranting further modelling and evaluation in drug research and development?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
40
0
1

Year Published

2010
2010
2015
2015

Publication Types

Select...
3
3
1

Relationship

1
6

Authors

Journals

citations
Cited by 46 publications
(41 citation statements)
references
References 44 publications
0
40
0
1
Order By: Relevance
“…[24][25][26] Likewise, little is known about the significance of acquired, e.g., drug-induced shortening of QTc and therapeutic consequences are uncertain. 23,27,28 Primidone and rufinamide can both shorten QTc, 29,30 but these drugs were not used in our patients. Although the use of carbamazepine could have influenced our results, this drug is associated with bradyarrhythmias and has only minor effects on QT intervals.…”
Section: Methodsmentioning
confidence: 90%
See 1 more Smart Citation
“…[24][25][26] Likewise, little is known about the significance of acquired, e.g., drug-induced shortening of QTc and therapeutic consequences are uncertain. 23,27,28 Primidone and rufinamide can both shorten QTc, 29,30 but these drugs were not used in our patients. Although the use of carbamazepine could have influenced our results, this drug is associated with bradyarrhythmias and has only minor effects on QT intervals.…”
Section: Methodsmentioning
confidence: 90%
“…Shortening of QT is substantially mediated by circulating catecholamines and can be enhanced by hyperkalemia and acidosis. 23,27,28,33 All these conditions occur particularly during or shortly after GTCS. 18,19,34 Furthermore, chronic epilepsy patients display altered autonomic function with a presumably increased sympathetic tone and enhanced QT dispersion (spatial heterogeneity of cardiac repolarization), which are both independent predictors of cardiac mortality.…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, evidence was provided that detection of delayed repolarization was not sufficient to determine proarrhythmic potentials. Lastly, preclinical safety pharmacology studies were suggested to include assessment of the potentials to shorten ventricular repolarization [4][5][6].…”
Section: Preclinical Models For Assessment Of Ion Channel-related Carmentioning
confidence: 99%
“…In addition to delayed ventricular repolarization, evidence was recently provided and discussed that shortening of ventricular repolarization is a risk factor for ventricular arrhythmias [4][5][6]. Only a few patients with congenital short QT syndrome (SQTS) have been described to date, but all suffer from an increased vulnerability to atrial and ventricular fibrillation and sudden cardiac death [7].…”
mentioning
confidence: 99%
“…There has long been a need arising from within the industry as well as from global regulatory authorities for the implementation of a certification process to confirm expertise and identify quality standards for professionals involved in the practice of SP. In response to such needs, SPS has provided recommendations on best practices in a form of peer-reviewed publications, as well as discussions during annual meetings (Authier, Vargas, Curtis, Holbrook, & Pugsley, 2013;Cavero, 2013Cavero, , 2014Holbrook, Malik, Shah, & Valentin, 2009;Leishman et al, 2012;Vargas et al, 2008).…”
mentioning
confidence: 99%